Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Generic Makers Permitted to Use Original Makers' ADR Data without Permission
April 28, 2008
- Half of Hepatitis C Patients who Stop IFN Treatment Do so Because of Cost
April 28, 2008
- 70% of Doctors Permit Substitution for Oral Vitamins
April 28, 2008
- Janssen to Launch 4 New Products per Year
April 28, 2008
- Will Generics Take Off? (1)
April 28, 2008
- Takeda Bio Development Center to Apply for 2 Products by 2010
April 28, 2008
- GENERICS NEWS IN BRIEF
April 28, 2008
- JHSF Proposes Support of Alliances
April 21, 2008
- JPMA Calls For Creation of Clinical Trials Centers
April 21, 2008
- Global Market for Drugs for Alzheimer's Disease to Expand to US$9.2 Bil.: Datamonitor
April 21, 2008
- R&D NEWS IN BRIEF（1）
April 21, 2008
- BUSINESS NEWS IN BRIEF
April 21, 2008
- R&D NEWS IN BRIEF（2）
April 21, 2008
- Orchid of India Announces Entry into Japanese Market
April 21, 2008
- NEW PRODUCTS
April 21, 2008
- Generic Makers to Embark on Mergers, Tie-ups: Mr Sawai
April 21, 2008
- NCC to Take Full Advantage of New System to Provide Advanced Healthcare to More Patients
April 21, 2008
- Doctors Should Collect Information Themselves when Using Generics: Prof. Ogata
April 21, 2008
- Further Spread of Hepatitis C Viral Infections Unlikely: Chugai Seminar
April 21, 2008
- Korosho to Punish Healthcare Providers Who Don't Try to Use More Generics: Mr Nakagaki
April 21, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…